Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-52411517EnglishN2023September11Healthcare
Human Papillomavirus(HPV) Vaccination in India: Challenges and The Way Forward
English0102Shivangi AgarwalEnglish Hephzibah Blessy JangiliEnglish
The World Health Organisation understands the importance of routine HPV vaccinationin national immunisation regimens because cervical cancer and other HPV-related illnesses are major global public health issues. Regardless of the Indian government’s efforts to include HPV vaccination in the National Immunisation Programme and decrease vaccine costs, there are significant barriers to vaccination implementation in India, including insufficient epidemiological evidence for illness prioritisation, vaccine duration, parental attitudes, and vaccine acceptance. Research studies should consider the wider context of improving life-long immunisation, comprehensive adolescent primary health care, and screening of cervical cancer. Educational measures for healthcare staff, followed by socially and culturally sensitive public awareness campaigns, are critical to meeting the WHO objective of eliminating cervical cancer by 2030.
EnglishCervical cancer, HPV vaccine, Human papillomavirus, Preventionhttp://ijcrr.com/abstract.php?article_id=4760http://ijcrr.com/article_html.php?did=4760
1. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby- Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health [Internet]. 2023 [cited 2023 Jul 18];11(2):e197–206. Available from: https://pubmed.ncbi.nlm.nih.gov/36528031/
2. Union Minister Dr Jitendra Singh announces India’s first indigenously developed vaccine, “CERVAVAC” for the prevention of cervical cancer [Internet]. Gov.in. [cited 2023 Jul 18]. Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1856034
3. Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status & current concepts. Indian J Med Res. 2018 Dec;148(6):687-696. doi: 10.4103/ijmr. IJMR_5_17. PMID: 30778002; PMCID: PMC6396551.
4. Mehrotra, R., Yadav, K. Cervical Cancer: Formulation and Implementation of Govt of India Guidelines for Screening and
Management. Indian J Gynecol Oncolog 20, 4 (2022). https:// doi.org/10.1007/s40944-021-00602-z
5. Shah P, Shetty V, Ganesh M, Shetty AK. Challenges to human Papillomavirus vaccine acceptability among women in south India: An exploratory study. Am J Trop Med Hyg [Internet]. 2021;105(4):966–73. Available from: http://dx.doi.org/10.4269/ ajtmh.20-1650
6. Coalition to STOP Cervical Cancer [Internet]. Paho.org. [cited 2023 May 20]. Available from: https://www.paho.org/hq/dmdocuments/ 2011/CCA_Strategies_HPV_vaccination_developing_ world.pdf
7. Prakash P, Raju P, HealthWorld ET. New qHPV vaccine: Dawn for cervical cancer prevention? [Internet]. ET Health World. 2022 [cited 2023 Jul 18]. Available from: https://health.economictimes. indiatimes.com/news/industry/new-qhpv-vaccinedawn- for-cervical-cancer-prevention/92878570
8. Unfpa.org. [cited 2023 May 20]. Available from: https://asiapacific. unfpa.org/en/publications/india-cervical-cancer-elimination- country-review-roadmap-action
9. Human papillomavirus vaccines: WHO position paper, December 2022 [Internet]. Who.int. World Health Organization; 2022 [cited 2023 May 20]. Available from: https://www.who.int/ publications/i/item/who-wer9750-645-672
Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-52411517EnglishN2023September11Healthcare
Artificial Intelligence in Medical Diagnostics and Drug discovery: A Review
English0310Varahalarao VadlapudiEnglish Sandeep KulkarniEnglish Dowluru SVGK KaladharEnglish Mutyala Naidu LagudaEnglish
Artificial intelligence (AI) is the field of computer sciences devoted to building smart machines capable of performing tasks that typically require human-level intelligence. The application of novel technologies like AI, machine learning (ML) and Deep learning (DL) in medical diagnostics could play a role in transforming the future of health care. Artificial neural networks such as deep neural networks or recurrent networks drive this area. AI helping patient care and intelligent health systems. AI can analyse identifying and diagnosing diseases more accurately and quickly. DL (a subset of ML) constitute the virtual component of AI plays a pivotal role in drug discovery. The widespread adoption of ML, in particular DL, in multiple scientific disciplines, and the advances in computing DL hardware and software, among other factors, continue to fuel this development-based approaches have only begun to address some fundamental problems in drug discovery. Research and development work is going worldwide. Here we tried to present AI application in various fields from health sector to drug discovery. We analysed the literature through PubMed and other ways of scientific search engines and also understand AI applications and presented in this paper. The finding are significant and understand how computational power is applied in the development of AI, its growing amount of digitized data, are analysed with accuracy and speed by AI. In this review, we discuss the basics of AI followed by an outline of its application in medical diagnostics and drug discovery.
EnglishArtificial intelligence, Machine learning, Deep learning, Health care, Algorithms, Drug discoveryhttp://ijcrr.com/abstract.php?article_id=4761http://ijcrr.com/article_html.php?did=4761
1. Schmidt-Erfurth U, Sadeghipour A, Gerendas BS, Waldstein SM, Bogunovi? H. Artificial intelligence in retina. Prog Retin
Eye Res. 2018; 67:1-29.
2. Hassoun S, Jefferson F, Shi X, Stucky B, Wang J, Rosa E. Artificial Intelligence for Biology. Integr Comp Biol. 2022
;61(6):2267-2275.
3. Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism. 2017:69S: S36-S40
4. Ramesh AN, Kambhampati C, Monson JR, Drew PJ. Artificial intelligence in medicine. Ann R Coll Surg Engl. 2004; 86(5):334-8.
5. Amisha, Malik P, Pathania M, Rathaur V.K. Overview of artificial intelligence in medicine. J Family Med Prim Care.
2019;8(7):2328-2331.
6. Kumar Y, Koul A, Singla R, Ijaz M.F. Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing
framework and future research agenda. J Ambient Intell Humaniz Comput. 2023;14(7):8459-8486
7. Burnett KG, Durica DS, Mykles DL, Stillman JH, Schmidt C. Recommendations for Advancing Genome to Phenome Research in Non-Model Organisms. Integr Comp Biol. 2020 ;60(2):397-401.
8. Shouval R, Fein JA, Savani B, Mohty M, Nagler A. Machine learning and artificial intelligence in haematology. Br J Haematol. 2021;192(2):239-250.
9. Walter W, Pohlkamp C, Meggendorfer M, Nadarajah N, Kern W, Haferlach C, et al. Artificial intelligence in hematological diagnostics: Game changer or gadget? Blood Rev. 2023;58:101019
10. Alami H, Lehoux P, Auclair Y, de Guise M, Gagnon MP, Shaw J, et al. Artificial Intelligence and Health Technology Assessment: Anticipating a New Level of Complexity. J Med Internet Res. 2020; 22(7):e17707.
11. Al-Antari MA. Artificial Intelligence for Medical Diagnostics- Existing and Future AI Technology! Diagnostics (Basel).
2023;13(4):688.
12. Shin Y, Yang J, Lee YH, Kim S. Artificial intelligence in musculoskeletal ultrasound imaging. Ultrasonography. 2021;40(1):30- 44
13. Kabongo JM, Nel S, Pitcher RD. Analysis of licensed South African diagnostic imaging equipment. Pan Afr Med J. 2015;22:57
14. Wasekar UW, Bathla R.K. Machine learning for diabetic retinopathy detection using image processing Int. J. Recent Technol. Eng: 2021; 9 (5):209-21516
15. Prabhu N, Bhoir D, Shanbhag N. Diabetic retinopathy screening using machine learning for hierarchical classification Int. J. Innov. Technol. Explor. Eng. 2019;8 (10): 1943-1948
16. Shravani HK. Lung cancer detection using local energy-based shape histogram (LESH) feature extraction using adaboost machine learning techniques. Int. J. Innov. Technol. Explor. Eng. 2020;9 (3) :167-171.
17. Li M, Ding Z, Gore JC. Identification of White Matter Networks Engaged in Object (Face) Recognition Showing Differential Responses to Modulated Stimulus Strength. Cereb Cortex Commun. 2020;1(1):tgaa067.
18. Laatifi M, Douzi S, Bouklouz A, Ezzine H , Jaafari J, Zaid Y, et al. Machine learning approaches in Covid-19 severity risk prediction in Morocco. J Big Data. 2022;9(1):5.
19. Abedi V, Khan A, Chaudhary D, Misra D, Avula V, Mathrawala D, et al. Using artificial intelligence for improving stroke diagnosis in emergency departments: a practical framework. Ther Adv Neurol Disord. 2020;13:1756286420938962.
20. Wahl B, Cossy-Gantner A, Germann S, Schwalbe N.R. Artificial intelligence (AI) and global health: how can AI contribute to health in resource-poor settings? BMJ Glob Health. 2018;3(4):e000798.
21. Owasis M, Arsalan M, Choi J, Mahmood T, Park K. Artificial intelligence-based classification of multiple gastrointestinal
diseases using endoscopy videos for clinical diagnosis. J Clin Med. 2019;8:786.
22. Nithya A, Ahilan A, Venkatadri N, Ramji D, Palagan A. Kidney disease detection and segmentation using artificial neural
network and multi kernel k-means clustering for ultrasound images. Measurement. 2020;149:106952
23. Alomari YM, Sheikh Abdullah SN, Zaharatul Azma R, Omar K. Automatic detection and quantification of WBCs and RBCs using iterative structured circle detection algorithm. Comput Math Methods Med. 2014; 979302.
24. Alférez S, Merino A, Bigorra L, Rodellar J. Characterization and automatic screening of reactive and abnormal neoplastic B lymphoid cells from peripheral blood. Int J Lab Hematol. 2016;38(2):209-19
25. Alférez S, Merino A, Mujica LE, Ruiz M, Bigorra L, Rodellar J. Automatic classification of atypical lymphoid B cells using digital blood image processing. Int J Lab Hematol. 2014;36(4):472- 80.
26. Kimura K, Tabe Y, Ai T Takehara I, Fukuda H, Takahashi H, et al. A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and A.A. Sci Rep. 2019;9(1):13385.
27. Wu YY, Huang T.C, Ye RH, Fang WH, Lai SW, Chang P.Y, et al. A Hematologist-Level Deep Learning Algorithm (BMSNet) for Assessing the Morphologies of Single Nuclear Balls in Bone Marrow Smears: Algorithm Development. JMIR Med Inform. 2020;8(4):e15963.
28. El Achi H, Khoury J.D. Artificial Intelligence and Digital Microscopy Applications in Diagnostic Hematopathology. Cancers (Basel). 2020;12(4):797.
29. Delshadpour S. Reduced size multi-layer perceptron neural network for human chromosome classification. In: Proceedings of the 25th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE Cat. No.03CH37439). IEEE. 2004; 3.2249–52.
30. Haferlach C, Hänselmann S, Walter W, Volkert S, Zenger M, Kern W, Haferlach T. Artificial intelligence substantially supports chromosome banding analysis maintaining its strengths in hematologic diagnostics even in the era of newer technologies. Blood. 2020;136:47–8.
31. Oskouei BC, Shanbehzadeh J. Chromosome classification based on wavelet neural network. In: 2010 International Conference on Digital Image Computing: Techniques and Applications. IEEE. 2010; 605–10.
32. Qiu Y, Lu X, Yan S, Tan M, Cheng S, Li S, et al. Applying deep learning technology to automatically identify metaphase chromosomes using scanning microscopic images: an initial investigation. In: Chen WR (ed). Biophotonics and Immune Responses XI. SPIE. 2016; 9709:
33. Sharma M, Saha O, Sriraman A, Hebbalaguppe R, Vig L, Karande S. Crowdsourcing for chromosome segmentation and deep classification. In: 2017 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW). IEEE. 2017; 786–93.
34. Wainberg M, Merico D, Delong A, Frey BJ. Deep learning in biomedicine. Nat Biotechnol. 2018;36(9):829-838.
35. Zou J, Huss M, Abid A, Mohammadi P, Torkamani A, Telenti A. A primer on deep learning in genomics. Nat Genet. 2019;
51(1):12–8.
36. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015; 521(7553): 436–444.
37. Dias R, Torkamani A. Artificial intelligence in clinical and genomic diagnostics. Genome Med. 2019;11(1):70.
38. Yoon J.H, Kim EK. Deep Learning-Based Artificial Intelligence for Mammography. Korean J Radiol. 2021: 22(8);1225-1239.
39. Sari CT, Gunduz-Demir C. Unsupervised feature extraction via deep learning for histopathological classification of colon tissue images. IEEE Trans Med Imaging. 2019;38(5):1139-1149.
40. Walsh S, de Jong EEC, van Timmeren JE, Ibrahim A, Compter I, Peerlings J, et al. Decision support systems in oncology. JCO Clin Cancer Inform. 2019;3(3):1–9.
41. Hekler A, Utikal J.S, Enk AH, Solass W, Schmitt M, Klode J, et al. Pathologist-level classification of histopathological melanoma images with deep neural networks. Eur J Cancer. 2019; 115:79-83.
42. Yousif M, van Diest PJ, Laurinavicius A, Rimm D, van der Laak J, Madabhushi A, Schnitt S, Pantanowitz L. Artificial
intelligence applied to breast pathology. Virchows Arch. 2022;480(1):191-209.
43. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018:68(6):394-424. Epub 2018 Sep 12. Erratum in: CA Cancer J Clin. 2020;70(4):313.
44. Ting DSW, Peng L, Varadarajan AV, Keane PA, Burlina PM, Chiang MF, et al. Deep learning in ophthalmology: the technical and clinical considerations. Prog Retin Eye Res. 2019; 72: 100759.
45. Campbell CG, Ting DSW, Keane PA, Foster PJ. The potential application of artificial intelligence for diagnosis and management of glaucoma in adults. Br Med Bull. 2020;134(1):21-33.
46. Wang P, Berzin TM, Brown JRG, Bharadwaj S, Becq A, Xiao, X et al.. Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: A prospective randomised controlled study. Gut 2019; 68: 1813–1819.
47. Tschandl P. Artificial intelligence for melanoma diagnosis. Ital J Dermatol Venerol. 2021;156(3): 289-299.
48. Kulkarni PM, Robinson EJ, Pradhan JS, Gartrell-Corrado R.D, Rohr BR, Trager M.H, et al. Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death. Clin Cancer
Res. 2020;26(5):1126-1134.
49. Crowley R.S, Legowski E, Medvedeva O, Tseytlin E, Roh E, Jukic D. Evaluation of an intelligent tutoring system in pathology: effects of external representation on performance gains, metacognition, and acceptance. J Am Med Inform Assoc. 2007;14(2):182-190.
50. Wells A, Patel S, Lee JB, Motaparthi K. Artificial intelligence in dermatopathology: Diagnosis, education, and research. J Cutan Pathol. 2021;48(8):1061-1068
51. Farah Y, Syed Muhammad IS, Aisha N, Syed Muhammad S, Adina J, Sana K, et al. Artificial intelligence in the diagnosis and detection of heart failure: the past, present, and future. Rev. Cardiovasc. Med. 2021; 22(4), 1095–1113.
52. Chen HY, Ge P, Liu JY, Qu JL, Bao F, Xu CM, et al. Artificial intelligence: Emerging player in the diagnosis and treatment of digestive disease. World J Gastroenterol. 2022; 28:28(20):2152- 2162.
53. Feigenbaum H. Evolution of echocardiography. Circulation. 1996;93(7):1321-7.
54. Liu J, Dan W, Liu X, Zhong X, Chen C, He Q, Wang J. Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine. Health Inf Sci Syst. 2023;11(1):21.
55. Verma RK, Pandey M, Chawla P, Choudhury H, Mayuren J, Bhattamisra SK, et al. An Insight into the Role of Artificial
Intelligence in the Early Diagnosis of Alzheimer’s Disease. CNS Neurol Disord Drug Targets. 2022; 21(10):901-912.
56. Dicle O. Artificial intelligence in diagnostic ultrasonography. Diagn Interv Radiol. 2023;29(1):40-45.
57. Hung K, Montalvao C, Tanaka R, Kawai T, Bornstein MM. The use and performance of artificial intelligence applications in dental and maxillofacial radiology: A systematic review. Dentomaxillofac Radiol. 2020;49(1):20190107.
58. Liscia DS, D’Andrea M, Biletta E, Bellis D, Demo K, Ferrero F, et al. Use of digital pathology and artificial intelligence for the diagnosis of Helicobacter pylori in gastric biopsies. Pathologica. 2022;114(4):295-303.
59. Hsiao Y.J, Wen Y.C, Lai W.Y, Lin Y.Y, Yang Y.P, Chien Y, et al. Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer. World J Gastroenterol. 2021;27(22).2979-2993.
60. Trasolini R, Byrne MF. Artificial intelligence and deep learning for small bowel capsule endoscopy. Dig Endosc. 2021;33(2):290- 297.
61. Biswas M, Kuppili V, Edla DR, Suri HS, Saba L, Marinhoe R.T, et al. Symtosis: A liver ultrasound tissue characterization and risk stratification in optimized deep learning paradigm. Comput Methods Programs Biomed. 2018;155:165–177.
62. Yuan Q, Zhang H, Deng T, Tang S, Yuan X, Tang W, et al. Role of Artificial Intelligence in Kidney Disease. Int J Med Sci. 2020; 17(7):970-984.
63. Gutman MJ, Schroeder GD, Murphy H, Flanders AE, Vaccaro AR. Artificial Intelligence in Spine Care. Clin Spine Surg.
2021;34(4):121-124.
64. Fedewa R, Puri R, Fleischman E, Lee J, Prabhu D, David et al. Artificial Intelligence in Intracoronary Imaging. Curr Cardiol Rep. 2020; 22(7):46.
65. Takamiya A, Tazawa Y, Kudo K, Kishimoto T. [Artificial Intelligence in Psychiatry]. Brain Nerve. 2019;71(1):15-23.
66. San José Estépar R. Artificial intelligence in functional imaging of the lung. Br J Radiol. 2022;95(1132):20210527.
67. Chan J, Auffermann WF. Artificial Intelligence in the Imaging of Diffuse Lung Disease. Radiol Clin North Am. 2022;60(6):1033- 1040.
68. Minoshima S, Cross D. Application of artificial intelligence in brain molecular imaging. Ann Nucl Med. 2022;36(2):103-110.
69. Huang X, Wang H, She C, Feng J, Liu X, Hu X, et al. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy. Front Endocrinol (Lausanne). 2022; 29:13:946915.
70. O’Connell AM, Bartolotta TV, Orlando A, Jung SH, Baek J, Parker KJ. Diagnostic Performance of an Artificial Intelligence System in Breast Ultrasound. J Ultrasound Med. 2022;41(1):97- 105.
71. Vogrin M, Trojner T, Kelc R. Artificial intelligence in musculoskeletal oncological radiology. Radiol Oncol. 2020;55(1):1-6.
72. Foo LL, Ng W.Y, Lim G.YS, Tan TE, Ang M, Ting DSW. Artificial intelligence in myopia: current and future trends. Curr Opin Ophthalmol. 2021;32(5):413-424.
73. Ou Q, Jin W, Lin L, Lin D, Chen K, Quan H. LASSO-based machine learning algorithm to predict the incidence of diabetes in different stages. Aging Male. 2023;26(1):2205510.
74. Li H, Chiang A.W.T, Lewis N.E. Artificial intelligence in the analysis of glycosylation data. Biotechnol Adv. 2022;60:108008.
75. Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Artificial Intelligence in Colorectal Cancer
Screening, Diagnosis and Treatment. A New Era. Curr Oncol. 2021;28(3):1581-1607.
76. Chassagnon G, Vakalopoulou M, Paragios N, Revel MP. Artificial intelligence applications for thoracic imaging. Eur J Radiol. 2020;123:108774.
77. Bradshaw TJ, McMillan AB. Anatomy and Physiology of Artificial Intelligence in PET Imaging. PET Clin. 2021;16(4):471-
482.
78. Waring MJ, Arrowsmith J, Leach A.R, Leeson P.D, Mandrell S, Owen R.M, et al. An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nat. Rev. Drug Discov. 2015;14:475–86.
79. Zhu H. Big Data and Artificial Intelligence Modelling for Drug Discovery. Annu Rev Pharmacol Toxicol. 2020;60:573-589.
80. Kayala MA, Azencott CA, Chen JH, Baldi P. Learning to predict chemical reactions. J Chem Inf Model. 2011;51(9):2209-22.
81. Sadowski P, Fooshee D, Subrahmanya N, Baldi P. Synergies Between Quantum Mechanics and Machine Learning in Reaction Prediction. J Chem Inf Model. 2016;56(11):2125-2128.
82. Hessler G, Baringhaus KH. Artificial Intelligence in Drug Design. Molecules. 2018;23(10):2520.
83. Hansch C, Fujita T. ρ-σ-π Analysis. A method for the correlation of biological activity and chemical structure. J. Am. Chem. Soc. 1964; 86:1616–26.
84. Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers. 2021;25(3):1315- 1360.
85. DiMasi JA, Faden LB. Competitiveness in follow-on drug R&D: a race or imitation? Nat Rev Drug Discov. 2011; 10(1):23-7.
86. Gawehn E, Hiss J.A, Schneider G. Deep Learning in Drug Discovery. Mol Inform. 2016;35(1):3-14.
87. Luukkonen S, van den Maagdenberg HW, Emmerich MTM, van Westen GJP. Artificial intelligence in multi-objective drug design. Curr Opin Struct Biol. 2023;79:102537.
88. Zhong F, Xing J, Li X, Liu X, Fu Z, Xiong Z, et al. Artificial intelligence in drug design. Sci China Life Sci. 2018; 61(10):1191- 1204.
89. Schneider G. Mind and machine in drug design. Nat. Mach. Intell. 2019;1(3):128–130.
90. Álvarez-Machancoses Ó, Fernández-Martínez JL. Using artificial intelligence methods to speed up drug discovery. Expert Opin Drug Discov. 2019;14(8):769-777.
91. Dana D, Gadhiya SV, St Surin LG, Li D, Naaz F, Ali Q, et al. Deep Learning in Drug Discovery and Medicine: Scratching the Surface. Molecules. 2018;23(9):2384.
92. MacEachern SJ, Forkert N D. Machine learning for precision medicine. Genome. 2021;64(4):416-425.
93. Nensa F, Demircioglu A, Rischpler C. Artificial Intelligence in Nuclear Medicine. J Nucl Med. 2019: 60(Suppl 2):29S-37S.
94. Merk D, Friedrich L, Grisoni F, Schneider G. De Novo Design of Bioactive Small Molecules by Artificial Intelligence. Mol Inform. 2018;37(1-2):1700153.
95. Mohanty S, Harun Ai Rashid M, Mridul M, Mohanty C, Swayamsiddha S. Application of Artificial Intelligence in COVID-19 drug repurposing. Diabetes Metab Syndr. 2020;14(5):1027- 1031.
96. Wieder R, Adam N. Drug repositioning for cancer in the era of AI big omics and real-world data. Crit Rev Oncol Hematol. 2022;175:103730.
97. Arora S, Chettri S, Percha V, Kumar D, Latwal M. Artificial intelligence: a virtual chemist for natural product drug discovery. J Biomol Struct Dyn. 2023;26:1-10.
98. Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395(10223):e30-e31.
99. Boniolo F, Dorigatti E, Ohnmacht AJ, Saur D, Schubert B, Menden MP. Artificial intelligence in early drug discovery
enabling precision medicine. Expert Opin Drug Discov. 2021;16(9):991-1007.
100. Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, et al. A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer. Cell. 2020;183(2):347-362.e24.
101. Fang J, Pieper AA, Nussinov R, Lee G, Bekris L, Leverenz JB, et al. Harnessing endophenotypes and network medicine for Alzheimer’s drug repurposing. Med Res Rev. 2020;40(6):2386- 2426.
102. Sahu A, Mishra J, Kushwaha N. Artificial Intelligence (AI) in Drugs and Pharmaceuticals. Comb Chem High Throughput Screen. 2022; 25(11):1818-1837.
103. Tanoli Z, Vähä-Koskela M, Aittokallio T. Artificial intelligence, machine learning, and drug repurposing in cancer. Expert Opin Drug Discov. 2021;16(9):977-989.
104. Zhou Y, Wang F, Tang J, Nussinov R, Cheng F. Artificial intelligence in COVID-19 drug repurposing. Lancet Digit Health. 2020; 2(12):e667-e676.
Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-52411517EnglishN2023September11Healthcare
Evaluation of Blood Pressure in Preterm Newborn and Long-Term Impacts of Hypotension on Neonatal Health
English1115Mannan MAEnglish Wahab AEnglish Yasmin FEnglish Hossain MAEnglish Akter SEnglish Moni SCEnglish Jahan IEnglish Chowdhury RMEnglish Shahidllah MEnglish
Introduction: Blood pressure values of too low or too high can be related with serious morbidity and mortality. Neonatal hypotension has been found to be related with serious short term as well as significant long term health complications. Thus identifying this low blood pressure in preterm neonates with its long term impacts is crucial.
Objectives: To evaluate blood pressure values in preterm newborn and long-term impacts of hypotension on neonatal health.
Methods: This prospective observational study was conducted in Neonatal Intensive Care Unit (NICU) of Bangabandhu Sheikh Mujib Medical University a tertiary care hospital of Dhaka city after approval from Institutional Review Board for a period of two years. Neonates having gestationEnglishPreterm, Hypotension, Neurodevelopmental Outcome, Morbidity, Mortality, Hemodynamic.http://ijcrr.com/abstract.php?article_id=4762http://ijcrr.com/article_html.php?did=4762
1. Gomella. T. ‘Neonatology: management, procedures, on-call problems, diseases and drugs', 8th edn, 2013 McGraw-Hill Education, New York, (2013) p- 555-562.
2. Dionne. J., Flynn. J., Management of severe hypertension in the newborn. Archives of Disease in Childhood, 2017.102(12):1176- 1179.
3. Matsushita. F., Krebs. V., de Carvalho. W., Neonatal Hypotension: What Is the Efficacy of Each Anti-Hypotensive Intervention? A Systematic Review. Current Treatment Options in Pediatrics, 2019. 5(4): 406-416.
4. Kent. A, Chaudhari. T. Determinants of Neonatal Blood Pressure. Current Hypertension Reports, 2013; 15(5): 426-432.
5. Joynt. C., Cheung. P., Treating Hypotension in Preterm Neonates with Vasoactive Medications. Frontiers in Pediatrics,
2018; 6 (5): 1-5.
6. Boode. W., Clinical monitoring of systemic hemodynamics incritically ill newborns. Early Human Development, 2010; 86(3): 137-141.
7. Bhupalam. P, Nalampati. S, Angiel. CJ, Gowthami. T, Narayana. G, Reddy. KS, et al. Influence of Low Birth Weight and Preterm Birth on Morbidity, Mortality and Medication Use among Neonates in Resource Limited Settings: A Prospective Observational Study. Int J Curr Res Rev. 2021;13.(22):80–5.
8. Alderliesten. T, Lemmers. PM, Van Haastert. IC. Hypotension in preterm neonates: low blood pressure alone does not affect neurodevelopmental outcome. J Pediatr, 2014;164 (5):986–91.
9. Lyu Y, Ye XY, Isayama T, Alvaro R, Nwaesei C, Barrington K, Lee SK, Shah PS; Canadian Neonatal Network Investigators. Admission Systolic Blood Pressure and Outcomes in PretermInfants of ≤ 26 Weeks' Gestation. Am J Perinatol. 2017 Nov;34 (13):1271-1278.
10. Logan JW, O'Shea TM, Allred EN, Laughon MM, Bose CL, Dammann O, Batton DG, Engelke SC, Leviton A; ELGAN
Study Investigators. Early postnatal hypotension and developmental delay at 24 months of age among extremely low gestational age newborns. Arch Dis Child Fetal Neonatal Ed. 2011 Sep;96(5): F321-8.